Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NIH Building Infrastructure Leading to Diversity (BUILD) II Initiative (U54 - Clinical Trial Not Allowed)

Notice Number: NOT-RM-18-005

Key Dates

Release Date: December 7, 2017
Estimated Publication Date of Funding Opportunity Announcement: 04/08/2018
First Estimated Application Due Date: 06/08/2018
Earliest Estimated Award Date: 07/01/2019
Earliest Estimated Start Date: 07/01/2019

Related Announcements

Issued by
Office of Strategic Coordination (Common Fund)


The Office of Strategic Coordination (Common Fund) intends to publish a funding opportunity announcement (FOA) for the final phase of the Building Infrastructure Leading to Diversity (BUILD) initiative, BUILD II. The FOA will solicit applications from the current BUILD awardees to continue the research on student, faculty, and institution-level interventions being performed for the Enhancing the Diversity of the NIH-Funded Workforce Program. This program, known as the Diversity Program Consortium (DPC), consists of three integrated initiatives: BUILD, the National Research Mentoring Network (NRMN), and the Coordination and Evaluation Center (CEC). The DPC is a Common Fund initiative (, developed through the NIH Office of the Director, Office of Strategic Coordination ( This Notice is to allow sufficient time to develop responsive applications. 

Continued Common Fund support for the DPC will provide the time and resources needed to (1) gather additional data to test site-specific and consortium-wide interventions; (2) transition into sustainable models for enhancing diversity in biomedical research fields; and (3) disseminate effective strategies to a broad range of institutions to have a lasting national impact. NIH intends that institutions not currently part of the DPC will have the opportunity to apply for funds to implement a DPC training, mentoring, or research capacity intervention in collaboration with funded BUILD or NRMN sites (see NOT-RM-18-007).

The initial phase of the BUILD program supported the development of 10 different experiments to test models for enhancing the diversity of the biomedical research workforce. The second and final phase of the BUILD initiative will allow sites that are deemed to have shown significant potential to finish their experiments in order to inform future diversity enhancement efforts at institutions across the country. BUILD sites that compete successfully will be expected to disseminate their models to other institutions. Because this second phase of the program is intended to allow successful BUILD sites to complete their experiments, report outcomes and disseminate successful models, the competition will be limited to the currently funded BUILD awardees.
The Funding Opportunity Announcement (FOA) will utilize the U54 activity code. Successful applicants will receive support through the Linked Specialized Center Cooperative agreement mechanism that includes a primary UL1 (Linked Specialized Center Cooperative Agreement) award, a RL5 (Linked Education Project) award and a TL4 (Linked Undergraduate Institutional Training) award. Details of the planned FOA are provided below.

Research Initiative Details

Applicants will be expected to draw from BUILD Phase I effective practices and the relevant literature to develop their plans for this final phase. The applicants should provide evidence that the scientific approach to training and mentoring interventions undertaken in Phase I is robust and is yielding interpretable rigorous results. BUILD II applicants must include a realistic budget as well as plans for a smooth transition to sustainable models, and for disseminating training or research capacity building interventions to a range of institution types.

Funding Information

Estimated Total Funding TBD
Expected Number of Awards 0-10
Estimated Award Ceiling TBD
Primary CFDA Numbers 93.310

Anticipated Eligible Organizations

Public/State Controlled Institution of Higher Education

Applications are not being solicited at this time.


Please direct all inquiries to:

Anissa Brown, Ph.D.
National Institute of General Medical Sciences